Brain Mechanisms Supporting Cannabis-induced Pain Relief
University of California, San Diego · NCT04982965
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- May 7, 2021
- Record last updated
- June 3, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Chronic low back pain is a common and disabling condition that affects millions of people in the United States. Many people with chronic low back pain do not get enough relief from current treatments. Cannabis may help reduce pain, but researchers do not fully understand how it affects the brain in people with chronic pain. The purpose of this study is to examine how inhaled cannabis changes brain activity and reduces pain in people with chronic low back pain. Results from this study may help researchers better understand how cannabis works for pain and support the development of improved pain treatments.
Being studied: Active Cannabis; Placebo Cannabis
Conditions: Sciatica; Lumbar Radiculopathy; Lower Back Pain; Degenerative Disc Disease; Chronic Low-back Pain (cLBP); Chronic Low Back and Leg Pain; Back Pain
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Between 21-65 years old
- Currently 30 days cannabis free
- Lower back pain for three months or more
- Are not taking opioids
- If female and of a child bearing potential age, are not pregnant or nursing mothers
- Do not have mental or neurological conditions inhibiting sensory/motor functions
- Do not have a lifetime history of dependence on cannabis
- Do not have a lifetime history of DSM-IV schizophrenia, bipolar disorder, panic disorder, or psychosis
- Prior THC-containing cannabis experience within the past two years
- Agrees not to use cannabis outside of the study during participation in the study
- Agrees not to use opioids or barbiturates during participation in the study
- Agrees not to drive a motor vehicle within 4 hours following last use of inhaled cannabis during participation in the study
Exclusion Criteria
- Active pulmonary disease
- Allergy or past adverse effects or negative past experiences from cannabis
- Positive urine drug test for THC, barbiturates, opioids, oxycodone, or methadone
- Any significant illness, including cardiovascular disease, diabetes, renal and liver disease.
- Any current or history of an immunocompromising disease or condition (such as lupus, psoriasis, multiple sclerosis, etc.)
- Any current or history of neurologic conditions, including Parkinson disease, dementia, cognitive impairment, history of seizure disorder, and history of traumatic brain injury/head injury
- Any current major psychiatric illness, such as bipolar disorder, major depression, psychosis, substance use disorder, or schizophrenia
- Any current or history of suicidal ideation or attempt
- Overt sensitivity to thermal stimulation
- Resting blood pressure > 140/90
- Resting heart rate > 100 beats/minute
- Prisoner
- Institutionalized
- Claustrophobia
- MRI contraindications
- Participation in any new (within 2 weeks prior or any time after enrollment) pain management procedures during the study period
- Known history of vasovagal fainting, syncope, or severe adverse reactions associated with blood draws or needle procedures
Recruiting US locations
Center for Functional MRI - W.M.Keck Building
La Jolla, CA 92093
Site contact: Madelynn Meredith, BS · 619-431-1850 · mameredith@health.ucsd.edu
Study contacts (from the official record)
- Madelynn Meredith, BS · 619-431-1850 · mameredith@health.ucsd.edu
- Yasmeen Esshaki, MA · 619-786-0375 · yesshaki@health.ucsd.edu
Similar studies in California
All pain studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
Adneuris Therapeutics, Inc.
- Location
- Riverside, CA + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
Vertanical GmbH
- Location
- Long Beach, CA + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Fresno, CA + 57 other US sites
- Eligibility basics
- Ages 18–80